Advanced Oncotherapy Share Discussion Threads

[daijavu] 09/5/2018 23:47

I have some faith in the technology and that it will work and do everything promised. However, I reserve judgement on the BoD of AVO and the survival of the company. Neither might be around when LIGHT is eventually brought to market by whatever company owns it by then.

The Chinese money has not been received, despite what make a million says, any more than it was received two years ago.

Two years ago, AVO announced multiple Chinese contracts, millions of pounds in Chinese investments, a major Chinese investor who was to buy £10 million of AVO shares, represent AVO in China and South East Asia and take a seat on the BoD of AVO.

It all came to nothing and has been erased from the record, along with those contracts, as if they had never happened.

Incidentally, the company is still controlled by the same people as then. They remain major shareholders even if they are not prominent on the BoD.

Just remember this, if a company appears undervalued, there is always a reason. The fault will either lie with a poor product or poor management. I don't think there is much wrong with AVO's product.

[paul_98] 09/5/2018 15:47

Let’s be positive. Life’s too short! SO much good going on here for shareholders and potential patients. GLA.

[andy] 09/5/2018 10:24

makeamillion,


Can you please explain how the website you quote is "linked to the market and share register"?

[igbertsponk] 09/5/2018 10:21

"directly linked to the share register"
LOL! How does it do that then?

[makeamillion1] 09/5/2018 08:23

JakNife

Answer yes I do totally trust this website it is directly linked to the market and share register.

Advanced Oncology website has not been updated since it still shows

Shares In Issue: 80,935,194 Last Updated: 30th January 2018.

Why are you so critical?

I have tried to contribute and comment as factually as possible on this board, unfortunately you seem to have a different agenda. I will leave you to believe your own views and wish you well.

[paul_98] 09/5/2018 07:12

Andy: I absolutely have faith in this. Cheers.

[makeamillion1] 09/5/2018 05:40

JacNife

I think you will be able to see the shares issued to Yantai CIPU here:

hxxp://www.4-traders.com/ADVANCED-ONCOTHERAPY-PLC-4006264/company/

I am pleased I can sleep at night as there are certainly a large number of skeptical posters who I guess must have unfortunately lost out in the past with this company. However for me I see a completely new horizon and this company now has some of the best professionals in the world working with them. In addition we have some seriously wealthy shareholders backing the company, for me following the money has paid off and I am really excited with what they are doing and the expertise around them. GLA. Lets see what the next news brings.

[scantrader] 09/5/2018 00:55

makeamillion - "most important treating superficial tumors by the end of Q3 this year has been reaffirmed as on track in the RNS today."

They still won't be actually treating any patients till - at best - late 2020.
Most superficial tumours are easily surgically removed = those in critical areas like the eyes are already treated on the NHS by low energy proton therapy, and by 2020 even high energy-capable proton centres will already be available in London and Manchester.

I doubt they'll get a smooth enough flow of private patients at Harley St to make an operating profit.

When and if AVO produces and certifies its full power units I doubt there'll be any firm commercial orders until/unless they've been demonstrated to be as reliable as the traditional technology.

[andy] 08/5/2018 23:52

Paul,

Exactly, who worries about little trivialities like whether funds have actually arrived or not?

[makeamillion1] 08/5/2018 22:12

JakNife, I think we will just agree to differ although I appreciate your view.

Looking at the share register Yantai CIPU Medical Technology Co.Ltd have currently 24,199,622 shares (16.1%) which I assume is not the full share allocation of 30% until the second payment for the distribution deal has been completed and the second payment of £16.5m received. Although this is pure speculation on my part as we do not have full sight of the Agreements signed in December.

It would seem quite extraordinary however to issue any shares without the receipt of funds and the company having received the first payment of £13.5m and with Yantai CIPU having 16.1% of the issued share capital may explain why no TR1 has been issued yet.

I can see the total shares are now 150,501,673 as detailed in the 16th February 2018 RNS, I can also see a float of 63,550,474 shares (42.2%).

What we do not know is what contingencies were written into the Agreement signed in December 2017 with respect to delays or not completing the distribution agreement, but I would expect there to have been some contractual obligations to complete the deal as a whole. In addition I would expect Mrs. Zhang RenHua and Mr. Chunlin Han will be appointed following the completion of the entire agreement announced on 7th December 2017 and following the required due diligence

I am not sure there is any other explanation, but perhaps you or anyone else may have other comments or knowledge.

[paul_98] 08/5/2018 20:25

I believe in them. It’s all going great in my eyes. I live in the present and then on to the future, which looks damn good to me! GLA

[makeamillion1] 08/5/2018 18:28

The shares have already been issued they would not have been issued without receipt of funds, this is standard practice and is never followed by another announcement because the announcement is the issuing of shares.

Please read this section of the 16th February release:

"As a consequence of the completion of the Subscription by Yantai Cipu, and as detailed in the circular dated 22 December 2017 (the "Circular"), the placing of 10,868,782 new ordinary shares with new and existing investors at the Subscription Price (the "Placing"), as well as the conversion of the loan made by Swedish Investors by way of issue of 13,697,697 new ordinary shares (the "Conversion"), have also been completed."

The relevant words are the first 3 words "As a consequence" and the last word in the paragraph "completed"

If you needed any further comfort the RNS issued on 3rd April confirms their considerable stake in the company......so fear not the company IMO is in very good shape.

[igbertsponk] 08/5/2018 17:50

That just says the money will be sent. Not that it has arrived. And certainly no holdings RNS issued afterwards.
Still in the post I reckon, like a lot of promised Chinese money.

[makeamillion1] 08/5/2018 17:36

Igbert Completion of subscription and receipt of £13.5m resulting in issue of shares confirmed on 16th February 2018.

hxxps://polaris.brighterir.com/public/advanced_oncotherapy/news/rns/story/w647q7x

[igbertsponk] 08/5/2018 17:30

Do we know for sure that the £13.5m was actually received?
Can't see anything definitive... and certainly no major holdings announcement.
Not on their website either...


Chinese money never to be counted on until you can count it out in notes.

[daijavu] 08/5/2018 17:14

makeamillion1.

I actually agree with some of what you say. However, I think that AVO is not out of the woods and the share price is likely to be a bit erratic for some time.

[makeamillion1] 08/5/2018 08:57

lol really I am loving this ride from 10p - 12p, great news today plus developments with Thales to scale up.

I have no concerns whatsoever with the Chinese money not coming through yet, there is no way that Yantai CIPU would have already subscribed for 45 million shares at 30p and paid £13.5 million if they had any doubts at all in their distribution partner.

IMHO the distribution licensing partner will be a well known and substantial partner in the Asia region, these things take time and so they should but rest assured when it is announced it will represent IMO another step change in the share.

The company currently has sufficient cash to be patient following the raising announced 7th December and as commented on here and other message boards there is much more news flow to come very soon like a further technical update, Circle Life's Birmingham site has been mentioned in previous analyst reviews and is expected to be announced, plus most important treating superficial tumors by the end of Q3 this year has been reaffirmed as on track in the RNS today.

The board and team as mentioned in the goetzpartners securities has changed significantly since 2016, it is a totally refocused company and not worthy of comparing to the past. Just highlighting what goetzpartners securities said:

"Reinforced management team changes the equity story significantly. AVOs management team has changed the equity story significantly compared to 2016. While the patents and the promising technology was already in place then, the company has added veterans of the PT industry from science, engineering, installation, application experience and compliance. We feel that the success of the industrialisation is entirely hinging on the top professionals."

I am looking forward to seeing what the market cap and share price will be following the announcement of superficial tumors being treated Q3 2018.

[daijavu] 08/5/2018 08:38

Igbert. I think you are reading too much into it. I think that Harley Street is still where the first machine will be used. It is just a disappointment that the timeline is so much longer than they promised.

[igbertsponk] 08/5/2018 08:26

So, reading between the lines, they hoped to build the thing at Harley Street, but delays there mean they've been forced to rent another site.

[daijavu] 08/5/2018 08:07

It is progress of a sort but where is the Chinese money?

[paul_98] 08/5/2018 07:41

Fantastic news this morning!